Finance

Beta
Senarai
Sektor ekuiti
Simbol
Simbol
Harga
Perubahan
% Perubahan
Arah aliran
Ditutup sebelum ini
Buka
Tinggi
Rendah
Volum
Permodalan Pasaran
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
BT3:FRA
Lineage Cell Therapeutics Inc
€1.11
+2.79%
(+0.030) 1H
22 Mei, 10:00:00 PTG GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk BT3...
Buka
€1.11
Tinggi
€1.11
Rendah
€1.11
Permodalan Pasaran
324.09J
Purata volum
288.00
Volum
0.00
tgi 52 mgu
€1.69
rdh 52 mgu
€0.42
Bilangan pekerja
75
Cerita berita
Daripada sumber merentas web
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Perihal Lineage Cell Therapeutics Inc
CEO-
Pekerja75
Diasaskan1990
Ibu pejabat-
Sektor-
Laman weblineagecell.com
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Penyata pendapatan
Hasil
Pendapatan bersih
Semua nilai dalam USD
Jun 2025
Sep 2025
Dis 2025
Mac 2026
Hasil
2.76J
3.68J
6.61J
1.72J
Kos barangan yang dijual
3.14J
184.00K
17.26J
-
Kos hasil
3.14J
184.00K
17.26J
-
Perbelanjaan penyelidikan dan pembangunan
-
3.09J
-8.96J
4.23J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
4.56J
4.19J
4.85J
5.08J
Belanja kendalian
4.56J
7.28J
-4.11J
9.32J
Jumlah belanja kendalian
7.70J
7.47J
13.16J
9.32J
Pendapatan kendalian
-4.94J
-3.79J
-6.55J
-7.59J
Pendapatan bukan kendalian lain
-12.71J
-26.56J
1.29J
2.32J
EBT termasuk item luar biasa
-30.36J
-29.75J
-4.39J
-4.79J
EBT tidak termasuk item luar biasa
-15.52J
-29.76J
-4.38J
-4.81J
Belanja cukai pendapatan
-
-
-5.28J
-
Kadar cukai berkesan
-
-
120.33%
-
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
-30.46J
-29.78J
851.00K
-4.81J
Margin untung bersih
-1,101.77%
-809.05%
12.88%
-278.96%
Perolehan bagi setiap syer
-0.13
-0.13
-
-0.02
Pendapatan faedah dan pelaburan
454.00K
366.00K
393.00K
405.00K
Belanja faedah
-
-
-
-
Belanja faedah bersih
454.00K
366.00K
393.00K
405.00K
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
-4.77J
-3.61J
-6.36J
-7.40J
Keuntungan atau kerugian daripada jualan aset
-
-
-
12.00K
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian

Penyelidikan

Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian